Cardiovascular diseases

This page brings together the European Medicines Agency's (EMA) latest information on diseases affecting the heart and blood vessels.

It lists the following:

• The newest and most recently updated medicines authorised for cardiovascular diseases in the European Union
• EMA's latest news announcements related to cardiovascular diseases
• EMA's upcoming events on cardiovascular topics

We are currently unable to display the new and recently updated medicines authorised for cardiovascular disease due to a technical error. We are working to resolve the issue as soon as possible. We apologise for any inconvenience caused.

Latest news

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 December 2023

EMA’s human medicines committee (CHMP) recommended seven medicines for approval at its December 2023 meeting.

15 décembre 2023

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 November 2023

PRAC recommends measures to minimise the risk of serious side effects with medicines containing pseudoephedrine.

1 décembre 2023

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 6-9 November 2023

EMA’s human medicines committee (CHMP) recommended eight medicines.

10 novembre 2023

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 23-26 October 2023

27 octobre 2023

SEE ALL NEWS

Events of interest

Currently, we have no events for this therapeutic area.